FR09C0037I2 - Virus de l'encephalite japonaise attenue, adapte a des cellules vero et vaccin contre l'encephalite japonaise - Google Patents
Virus de l'encephalite japonaise attenue, adapte a des cellules vero et vaccin contre l'encephalite japonaiseInfo
- Publication number
- FR09C0037I2 FR09C0037I2 FR09C0037C FR09C0037C FR09C0037I2 FR 09C0037 I2 FR09C0037 I2 FR 09C0037I2 FR 09C0037 C FR09C0037 C FR 09C0037C FR 09C0037 C FR09C0037 C FR 09C0037C FR 09C0037 I2 FR09C0037 I2 FR 09C0037I2
- Authority
- FR
- France
- Prior art keywords
- japanese encephalitis
- attenuated
- vero cell
- vaccine
- encephalitis virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229940124726 Japanese encephalitis vaccine Drugs 0.000 title 1
- 241000710842 Japanese encephalitis virus Species 0.000 title 1
- 229940124868 Japanese encephalitis virus vaccine Drugs 0.000 title 1
- 230000002238 attenuated effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24151—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR19970042001 | 1997-08-28 | ||
KR19970042002 | 1997-08-28 | ||
PCT/KR1998/000259 WO1999011762A1 (fr) | 1997-08-28 | 1998-08-25 | Virus de l'encephalite japonaise attenue, adapte a des cellules vero et vaccin contre l'encephalite japonaise |
Publications (2)
Publication Number | Publication Date |
---|---|
FR09C0037I1 FR09C0037I1 (fr) | 2009-09-25 |
FR09C0037I2 true FR09C0037I2 (fr) | 2021-11-05 |
Family
ID=26633032
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR09C0037C Active FR09C0037I2 (fr) | 1997-08-28 | 2009-08-14 | Virus de l'encephalite japonaise attenue, adapte a des cellules vero et vaccin contre l'encephalite japonaise |
Country Status (15)
Country | Link |
---|---|
US (1) | US6309650B1 (fr) |
EP (2) | EP1025209B1 (fr) |
JP (1) | JP4161017B2 (fr) |
KR (1) | KR100314404B1 (fr) |
CN (1) | CN1142271C (fr) |
AU (1) | AU748730B2 (fr) |
CA (1) | CA2301000C (fr) |
DE (2) | DE122009000037I2 (fr) |
DK (2) | DK1604685T3 (fr) |
ES (2) | ES2382946T3 (fr) |
FR (1) | FR09C0037I2 (fr) |
MY (1) | MY129773A (fr) |
NL (1) | NL300391I2 (fr) |
NZ (1) | NZ503522A (fr) |
WO (1) | WO1999011762A1 (fr) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000083657A (ja) * | 1998-07-13 | 2000-03-28 | Chemo Sero Therapeut Res Inst | 日本脳炎ウイルスワクチン |
AU743546B2 (en) | 1998-10-05 | 2002-01-31 | Research Foundation For Microbial Diseases Of Osaka University, The | Enhanced immunogen for inactivated vaccine for infection with Japanese encephalitis viruses and process for producing the same |
CA2650236C (fr) * | 1999-04-22 | 2016-01-12 | United States Of America, As Represented By The Secretary Of Agriculture | Vaccin contre le syndrome dysgenesique respiratoire porcin base sur l'isolat ja-142 |
JP4751558B2 (ja) * | 2000-04-07 | 2011-08-17 | 一般財団法人化学及血清療法研究所 | 日本脳炎不活化ワクチン及びその製造方法 |
BR0210628A (pt) * | 2001-06-29 | 2004-08-10 | Becton Dickinson Co | Liberação intradérmica de vacinas e agentes terapêuticos genéticos via microcânula |
JP2007068401A (ja) * | 2003-08-07 | 2007-03-22 | Chemo Sero Therapeut Res Inst | 西ナイルウイルスワクチン |
WO2005080556A2 (fr) * | 2004-02-23 | 2005-09-01 | Crucell Holland B.V. | Procedes de purification de virus |
CN100340596C (zh) * | 2004-05-20 | 2007-10-03 | 佛山市顺德区汉达精密电子科技有限公司 | 回收聚碳酸酯/丙烯腈-丁二烯-苯乙烯共聚物及其回收方法 |
WO2006108707A1 (fr) * | 2005-04-11 | 2006-10-19 | Crucell Holland B.V. | Purification de virus faisant appel a une ultrafiltration |
CA2676775A1 (fr) * | 2007-01-31 | 2008-09-25 | Sanofi Pasteur Biologics Co. | Vecteur vaccinal flavivirus contre le virus de la grippe |
KR20160003301A (ko) * | 2007-12-26 | 2016-01-08 | 기타사토 다이이치 산쿄 백신 가부시키가이샤 | 안정하게 장기간 보존할 수 있는 일본뇌염 백신의 제조방법 및 그 백신의 용도 |
KR101507822B1 (ko) | 2008-06-04 | 2015-04-24 | 잇빤 자이단호진 가가쿠오요비겟세이료호겐쿠쇼 | 불활성화 일본 뇌염 바이러스 입자를 어쥬번트로서 사용하는 방법 |
JP5744517B2 (ja) * | 2008-07-30 | 2015-07-08 | 久光製薬株式会社 | マイクロニードルデバイスおよびマイクロニードルデバイスによる日本脳炎ウイルス抗原の奏功性を上昇させる方法 |
WO2010137036A2 (fr) * | 2009-05-25 | 2010-12-02 | Panacea Biotec Ltd | Nouveau vaccin contre l'encéphalite japonaise et procédé de fabrication correspondant |
KR101144993B1 (ko) * | 2009-06-18 | 2012-06-27 | 대한민국 | 돼지 일본뇌염 바이러스의 고농축 혈구응집용 항원 |
PT3269386T (pt) | 2011-12-06 | 2022-12-05 | Valneva Austria Gmbh | Compostos de alumínio para utilização em terapêuticas e vacinas |
CN105744952A (zh) * | 2013-09-14 | 2016-07-06 | 巴拉特生物技术国际有限公司 | 病毒疫苗及其制备方法 |
CN105695424B (zh) * | 2015-04-01 | 2019-06-14 | 中国食品药品检定研究院 | 乙型脑炎减毒活疫苗株sa14-14-2在人二倍体细胞2bs上的适应株及其疫苗 |
EP4253403A3 (fr) | 2015-12-23 | 2023-12-27 | Valneva Austria GmbH | Procédé de purification du virus zika |
KR102405736B1 (ko) * | 2016-01-15 | 2022-06-07 | 케이엠 바이올로직스 가부시키가이샤 | 고정화 바이러스 입자를 포함하는 백신 |
WO2017210215A1 (fr) | 2016-05-31 | 2017-12-07 | The Government Of The United States Of America As Represented By The Secretary Of The Army | Vaccin contre le virus zika et procédés d'utilisation |
JP7301811B2 (ja) | 2017-09-21 | 2023-07-03 | ヴァルネヴァ エスイー | 免疫原性チクングニアウイルスchikv-delta 5nsp3を含む医薬組成物を製造する方法 |
CA3081578A1 (fr) | 2017-11-03 | 2019-05-09 | Takeda Vaccines, Inc. | Vaccins et compositions immunogenes anti-zika, et leurs procedes d'utilisation |
BR112020010466A2 (pt) | 2017-11-30 | 2020-11-24 | Takeda Vaccines, Inc. | composições imunogênicas e vacinas contra zika, métodos de uso das mesmas |
CN110684747B (zh) * | 2018-07-06 | 2024-05-24 | 厦门大学 | 灭活及保存呼吸道合胞病毒的方法 |
EP3845639A4 (fr) * | 2018-08-27 | 2022-05-11 | Mican Technologies Inc. | Procédé d'évaluation de médicaments anti-infectieux, vaccins, etc. utilisation de cellules monocytaires immortalisées et de cellules induites |
EP3895729A1 (fr) | 2020-03-01 | 2021-10-20 | Valneva Austria GmbH | Vaccin contre le virus sars-cov-2 adjuvé par cpg |
JP2023515908A (ja) | 2020-03-01 | 2023-04-14 | ヴァルネヴァ・オーストリア・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | CpGアジュバント化SARS-CoV-2ウイルスワクチン |
WO2021204825A2 (fr) | 2020-04-06 | 2021-10-14 | Valneva Austria Gmbh | Vaccin à virus sars-cov-2 inactivé |
WO2023148256A1 (fr) | 2022-02-02 | 2023-08-10 | Valneva Austria Gmbh | Vaccin à virus sars-cov-2 inactivé |
WO2024153686A1 (fr) | 2023-01-18 | 2024-07-25 | Valneva Austria Gmbh | Procédé de production de virus dans un bioréacteur |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2704258B2 (ja) * | 1987-10-31 | 1998-01-26 | 日本臓器製薬株式会社 | 組み換えワクチニアウイルス |
GB8821656D0 (en) * | 1988-09-15 | 1988-10-12 | Health Lab Service Board | Pharmaceutical compositions for eliciting immunostimulant effect |
JPH085803B2 (ja) * | 1988-11-10 | 1996-01-24 | 武田薬品工業株式会社 | 日本脳炎ワクチンの製造法 |
EP0562136A1 (fr) * | 1992-03-24 | 1993-09-29 | Division Of Microbiology, Kyoto Biken Laboratories, Inc. | Vaccin vivant contre les infections à virus getah, et vaccin vivant trivalent contre le virus de l'encéphalite japonaise, le parvovirus porcin et le virus getah |
US6010894A (en) * | 1997-06-13 | 2000-01-04 | Research Development Foundation | Method of screening for attenuating viruses |
-
1998
- 1998-08-25 DK DK05014317.1T patent/DK1604685T3/da active
- 1998-08-25 JP JP2000508774A patent/JP4161017B2/ja not_active Expired - Lifetime
- 1998-08-25 NZ NZ503522A patent/NZ503522A/en not_active IP Right Cessation
- 1998-08-25 WO PCT/KR1998/000259 patent/WO1999011762A1/fr active IP Right Grant
- 1998-08-25 ES ES05014317T patent/ES2382946T3/es not_active Expired - Lifetime
- 1998-08-25 DE DE122009000037C patent/DE122009000037I2/de active Active
- 1998-08-25 US US09/486,392 patent/US6309650B1/en not_active Expired - Lifetime
- 1998-08-25 CA CA002301000A patent/CA2301000C/fr not_active Expired - Lifetime
- 1998-08-25 EP EP98941885A patent/EP1025209B1/fr not_active Expired - Lifetime
- 1998-08-25 CN CNB988097974A patent/CN1142271C/zh not_active Expired - Lifetime
- 1998-08-25 DE DE69837211T patent/DE69837211T2/de not_active Expired - Lifetime
- 1998-08-25 DK DK98941885T patent/DK1025209T3/da active
- 1998-08-25 ES ES98941885T patent/ES2281929T3/es not_active Expired - Lifetime
- 1998-08-25 EP EP05014317A patent/EP1604685B1/fr not_active Expired - Lifetime
- 1998-08-25 AU AU90047/98A patent/AU748730B2/en not_active Expired
- 1998-08-26 MY MYPI98003899A patent/MY129773A/en unknown
- 1998-08-27 KR KR1019980035007A patent/KR100314404B1/ko not_active IP Right Cessation
-
2009
- 2009-06-10 NL NL300391C patent/NL300391I2/nl unknown
- 2009-08-14 FR FR09C0037C patent/FR09C0037I2/fr active Active
Also Published As
Publication number | Publication date |
---|---|
NL300391I2 (nl) | 2009-11-02 |
DE122009000037I2 (de) | 2011-06-16 |
JP4161017B2 (ja) | 2008-10-08 |
ES2281929T3 (es) | 2007-10-01 |
WO1999011762A1 (fr) | 1999-03-11 |
KR100314404B1 (ko) | 2002-10-12 |
NL300391I1 (nl) | 2009-08-03 |
DE69837211T2 (de) | 2007-12-06 |
CA2301000C (fr) | 2003-07-08 |
DE122009000037I1 (de) | 2009-11-05 |
MY129773A (en) | 2007-04-30 |
DK1025209T3 (da) | 2007-06-25 |
EP1604685A3 (fr) | 2006-07-05 |
NZ503522A (en) | 2001-06-29 |
DE69837211D1 (de) | 2007-04-12 |
US6309650B1 (en) | 2001-10-30 |
CN1272879A (zh) | 2000-11-08 |
KR19990023955A (ko) | 1999-03-25 |
FR09C0037I1 (fr) | 2009-09-25 |
EP1025209B1 (fr) | 2007-02-28 |
EP1604685A2 (fr) | 2005-12-14 |
CN1142271C (zh) | 2004-03-17 |
ES2382946T3 (es) | 2012-06-14 |
CA2301000A1 (fr) | 1999-03-11 |
EP1025209A1 (fr) | 2000-08-09 |
AU748730B2 (en) | 2002-06-13 |
AU9004798A (en) | 1999-03-22 |
JP2001514844A (ja) | 2001-09-18 |
DK1604685T3 (da) | 2012-06-18 |
EP1604685B1 (fr) | 2012-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR09C0037I2 (fr) | Virus de l'encephalite japonaise attenue, adapte a des cellules vero et vaccin contre l'encephalite japonaise | |
GB2337755B (en) | Virus vaccine | |
PL324906A1 (en) | Vaccines against viral hepatitis of c type | |
EP1112091A4 (fr) | Sterilisation cryogenique rapide et preparation de vaccin | |
NO20004104D0 (no) | Preparater omfattende virus og fremgangsmÕter for konsentrering av viruspreparater | |
HUP0003911A3 (en) | Treatment of neoplasms with viruses | |
AP9701060A0 (en) | Hepatitis B vaccine | |
IL130582A0 (en) | Rapidly releasing and taste-masking pharaceeeutical dosage form | |
AU7501898A (en) | Live attenuated virus vaccines for equine encephalitis viruses | |
DZ1706A1 (fr) | Vaccin contre le virus de l'hepatite a. | |
NZ310055A (en) | Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection | |
IS5777A (is) | Bóluefnisvakið lifrarbólgu B veiruafbrigði og notkun þess | |
HK1024262A1 (en) | Immunogenic peptides of foot-and-mouth disease viruses | |
EP0868196A4 (fr) | Vaccin de synthese pour la protection contre l'infection par le virus de l'immunodeficience humaine | |
AU4529401A (en) | Aids ancestral viruses and vaccines | |
EP1113777A4 (fr) | Nouveaux peptides du virus de l'hepatite c et utilisations de ceux-ci | |
GB9702990D0 (en) | Virus vaccine | |
GB9423663D0 (en) | Viral preparations, immunogens, and vaccines | |
PT841943E (pt) | Virus herpeticos avirulentos uteis como agentes tumoricidas e vacinas | |
AU8096998A (en) | Attenuated human immunodeficiency virus vaccine | |
AU7276198A (en) | Live virus vaccines to protect primates from hiv-1 infection and disease | |
GB9816773D0 (en) | Virus vectors and expression elements,their preparation and use | |
GB9503395D0 (en) | Viral,preparations,immunogens,and vaccines | |
EP1229042A4 (fr) | Peptides cycliques et vaccins contre le sida | |
GB9620856D0 (en) | Virus vaccine |